OSCR - NYSE
Oscar Health, Inc.
$23.54
+14%Oscar Health, Inc. provides health insurance products and services in the United States. The company offers Individual & Family, Small Group, and Medicare Advantage plans, as well as +Oscar, a technology driven platform designed to help providers and payor clients to engage with members and patients. It also provides reinsurance products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021. Oscar Health, Inc. was incorporated in 2012 and is headquartered in New York, New York.
At a Glance
Live Snapshotoscr
Net Cash Provided by Financing Activities
Last Annual Value
399.21M
3-Year CAGR
10%
5-Year CAGR
-8%
10-Year CAGR
69%
Oscar Health, Inc. Competitors Analysis of Net Cash Provided by Financing Activities
| Company | Net Cash Provided by Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
Oscar Health, Inc. NYSE:OSCR | 399.21M | 295.6% | -20.3% | N/A | |
 Option Care Health, Inc. NASDAQ:OPCH | -277.31M | N/A | N/A | N/A | |
 Arcellx, Inc. NASDAQ:ACLX | 98.53M | -29.3% | -3.6% | N/A | |
 TransMedics Group, Inc. NASDAQ:TMDX | 16.86M | -65.2% | 64.7% | -12.4% | |
 Hinge Health, Inc. NYSE:HNGE | -150.47M | N/A | N/A | N/A | |
 Kymera Therapeutics, Inc. NASDAQ:KYMR | 990.71M | 518.3% | 31.7% | N/A | |
 NewAmsterdam Pharma Company N.V. NASDAQ:NAMS | 29.52M | 49.1% | -19.0% | N/A | |
 Immunovant, Inc. NASDAQ:IMVT | 595.76M | 103.3% | 9.2% | N/A | |
 Viking Therapeutics, Inc. NASDAQ:VKTX | 76.44M | -34.4% | 61.9% | 22.1% | |
 Alignment Healthcare, Inc. NASDAQ:ALHC | 18.04M | 455.9% | -45.1% | N/A | |
 Akero Therapeutics, Inc. NASDAQ:AKRO | 445.85M | 8.1% | 274.9% | N/A |
Oscar Health, Inc. Fair Value Envelope
Related Guides
Continue your OSCR research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.